CNBC.com's MacKenzie Sigalos has the day's top business news headlines. Pfizer submitted its Covid-19 vaccine to the FDA for emergency authorization today, kicking off the first step of the approval and deployment process. But CNBC's Bertha Coombs explains how, at the same time, the combination of rising infection and Thanksgiving travel prep is putting a strain on some clinics that offer tests for the virus. Plus, the "After Hours" team dives into the rave reviews for Apple's new M1 chips.
12:01
Fri, Nov 20 20206:06 PM EST
"use" - Google News
November 21, 2020 at 06:14AM
https://ift.tt/2KkIoQa
Pfizer applies for emergency use of Covid-19 vaccine amid testing bottleneck - CNBC
"use" - Google News
https://ift.tt/2P05tHQ
https://ift.tt/2YCP29R
Bagikan Berita Ini
0 Response to "Pfizer applies for emergency use of Covid-19 vaccine amid testing bottleneck - CNBC"
Post a Comment